Today, we discuss Trump’s lofty new health plan, see the FDA delay two drug reviews under the new voucher program, and more.

A new obesity drug that Eli Lilly is researching but hasn't approved is turning up online, even though it's not supposed to be available.

Eli Lilly (LLY) stock slips as the FDA decision on the company's obesity pill orforglipron is now due in April, which ...

From a household robot that can do your chores for you to a stair-climbing robo vac, these products caught my eye ...

Eli's Hormometer is an innovative kit and app system for checking hormone levels at home. While not intended as a clinical or ...

Eli Health has expanded its saliva-based hormone tests to include testosterone and progesterone, using just a stick, your phone, and some spit.

At last year’s CES, Eli Health announced the Hormometer — an at-home hormone test for cortisol that utilized saliva and a ...

The legislation, expected to come to a vote next week, would make changes that could eventually affect health care costs but are unlikely to immediately curb rising premiums. By Michael Gold and ...

Even with two failed votes in the Senate, and the real risk of disastrous midterm elections, House Republicans remain deeply divided on the issue of the subsidies. Because of that division — and ...

House Republicans on Friday unveiled a health care bill they will bring to a vote next week that includes items that are broadly popular in the party, like cost sharing reductions and reforms to the ...